ESTRO (European Society for Radiotherapy and Oncology) shared a post on LinkedIn:
”20 abstracts on prostate brachytherapy were selected for presentation at ESTRO24. Highlights of the key findings that were presented onsite included combining brachytherapy/ I-RT with SBRT, local control, impact of comorbidities, EMT measurements, and comparative toxicity analysis.”
Read further.
Source: ESTRO/LinkedIn